Correction: Efficacy of NKG2D CAR-T cells with IL-15/IL-15Rα signaling for treating Epstein-Barr virus-associated lymphoproliferative disorder
Crossref DOI link: https://doi.org/10.1186/s40164-024-00559-7
Published Online: 2024-09-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mai, Qiusui
He, Bailin
Deng, Shikai
Zeng, Qing
Xu, Yanwen
Wang, Cong
Pang, Yunyi
Zhang, Sheng
Li, Jinfeng
Zeng, Jinfeng
Huang, Liqin
Fu, Yongshui
Li, Chengyao
Li, Tingting
Xu, Xiaojun
Zhang, Ling
Text and Data Mining valid from 2024-09-12
Version of Record valid from 2024-09-12
Article History
First Online: 12 September 2024